{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:14:13Z","timestamp":1740143653249,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T00:00:00Z","timestamp":1614470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T00:00:00Z","timestamp":1614470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10014-021-00394-2","type":"journal-article","created":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T01:02:42Z","timestamp":1614474162000},"page":"132-137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Concomitant KIAA1549-BRAF fusion and IDH mutation in Pediatric spinal cord astrocytoma: a case report and literature review"],"prefix":"10.1007","volume":"38","author":[{"given":"Mengxue","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dehong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhilian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianghong","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6081-1129","authenticated-orcid":false,"given":"Yueshan","family":"Piao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,28]]},"reference":[{"key":"394_CR1","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/j.1750-3639.2012.00603.x","volume":"22","author":"M Badiali","year":"2012","unstructured":"Badiali M, Gleize V, Paris S, Moi L, Elhouadani S, Arcella A, Morace R, Antonelli M, Buttarelli FR, Figarella-Branger D, Kim YH, Ohgaki H, Mokhtari K, Sanson M, Giangaspero F (2012) KIAA1549-BRAF fusions and IDH mutations can coexist in diffuse gliomas of adults. Brain Pathol 22:841\u2013847","journal-title":"Brain Pathol"},{"key":"394_CR2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00401-008-0455-2","volume":"116","author":"J Balss","year":"2008","unstructured":"Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A (2008) Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 116:597\u2013602","journal-title":"Acta Neuropathol"},{"key":"394_CR3","doi-asserted-by":"crossref","unstructured":"Behling F, Schittenhelm J (2019) Oncogenic BRAF Alterations and Their Role in Brain Tumors. Cancers (Basel) 11:794","DOI":"10.3390\/cancers11060794"},{"key":"394_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11060-014-1398-1","volume":"117","author":"GR Cruz","year":"2014","unstructured":"Cruz GR, Dias Oliveira I, Moraes L, Del Giudice PM, de Seixas Alves MT, Capellano AM, Saba-Silva N, Cavalheiro S, Cerutti JM, Toledo SR (2014) Analysis of KIAA1549-BRAF fusion gene expression and IDH1\/IDH2 mutations in low grade pediatric astrocytomas. J Neurooncol 117:235\u2013242","journal-title":"J Neurooncol"},{"key":"394_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00401-012-1011-7","volume":"124","author":"B Ellezam","year":"2012","unstructured":"Ellezam B, Theeler BJ, Walbert T, Mammoser AG, Horbinski C, Kleinschmidt-DeMasters BK, Perry A, Puduvalli V, Fuller GN, Bruner JM, Aldape KD (2012) Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas. Acta Neuropathol 124:449\u2013451","journal-title":"Acta Neuropathol"},{"key":"394_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00432-015-2006-2","volume":"142","author":"M Gierke","year":"2016","unstructured":"Gierke M, Sperveslage J, Schwab D, Beschorner R, Ebinger M, Schuhmann MU, Schittenhelm J (2016) Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification. J Cancer Res Clin Oncol 142:89\u2013100","journal-title":"J Cancer Res Clin Oncol"},{"key":"394_CR7","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"GRB Helen Davies","year":"2002","unstructured":"Helen Davies GRB, Cox C, Stephens P et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949\u2013954","journal-title":"Nature"},{"key":"394_CR8","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s00586-012-2345-5","volume":"21","author":"K Hirano","year":"2012","unstructured":"Hirano K, Imagama S, Sato K, Kato F, Yukawa Y, Yoshihara H, Kamiya M, Deguchi M, Kanemura T, Matsubara Y, Inoh H, Kawakami N, Takatsu T, Ito Z, Wakao N, Ando K, Tauchi R, Muramoto A, Matsuyama Y, Ishiguro N (2012) Primary spinal cord tumors: review of 678 surgically treated patients in Japan. A multicenter study. Eur Spine J 21:2019\u20132026","journal-title":"Eur Spine J"},{"key":"394_CR9","doi-asserted-by":"publisher","first-page":"414","DOI":"10.4103\/1793-5482.228540","volume":"13","author":"SA Javadi","year":"2018","unstructured":"Javadi SA, Hartmann C, Walter GF, Banan R, Samii A (2018) IDH1 mutation in brain stem glioma: case report and review of literature. Asian J Neurosurg 13:414\u2013417","journal-title":"Asian J Neurosurg"},{"key":"394_CR10","doi-asserted-by":"publisher","first-page":"8673","DOI":"10.1158\/0008-5472.CAN-08-2097","volume":"68","author":"DT Jones","year":"2008","unstructured":"Jones DT, Kocialkowski S, Liu L, Pearson DM, Backlund LM, Ichimura K, Collins VP (2008) Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68:8673\u20138677","journal-title":"Cancer Res"},{"key":"394_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1470-2045(10)70053-X","volume":"12","author":"NK Kloosterhof","year":"2011","unstructured":"Kloosterhof NK, Bralten LBC, Dubbink HJ, French PJ, van den Bent MJ (2011) Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma? Lancet Oncol 12:83\u201391","journal-title":"Lancet Oncol"},{"key":"394_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00401-009-0550-z","volume":"118","author":"A Korshunov","year":"2009","unstructured":"Korshunov A, Meyer J, Capper D, Christians A, Remke M, Witt H, Pfister S, von Deimling A, Hartmann C (2009) Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma. Acta Neuropathol 118:401\u2013405","journal-title":"Acta Neuropathol"},{"key":"394_CR13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820","journal-title":"Acta Neuropathol"},{"key":"394_CR14","doi-asserted-by":"crossref","unstructured":"Matsumura N, Ikota H, Yamazaki T, Nakata S, Nobusawa S, Hirato J, Yoshimoto Y, Yokoo H (2018) Cerebellar high-grade astrocytoma with IDH mutations in the elderly: A report of two cases. Neuropathology 38:411\u2013416","DOI":"10.1111\/neup.12468"},{"key":"394_CR15","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1038\/onc.2011.160","volume":"30","author":"G Maurer","year":"2011","unstructured":"Maurer G, Tarkowski B, Baccarini M (2011) Raf kinases in cancer-roles and therapeutic opportunities. Oncogene 30:3477\u20133488","journal-title":"Oncogene"},{"key":"394_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10014-012-0099-8","volume":"30","author":"H Oka","year":"2013","unstructured":"Oka H, Utsuki S, Tanizaki Y, Hagiwara H, Miyajima Y, Sato K, Kusumi M, Kijima C, Fujii K (2013) Clinicopathological features of human brainstem gliomas. Brain Tumor Pathol 30:1\u20137","journal-title":"Brain Tumor Pathol"},{"key":"394_CR17","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016. Neuro Oncol 21:v1\u2013v100","journal-title":"Neuro Oncol"},{"key":"394_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fonc.2015.00054","volume":"5","author":"CL Penman","year":"2015","unstructured":"Penman CL, Faulkner C, Lowis SP, Kurian KM (2015) Current Understanding of BRAF alterations in diagnosis, prognosis, and therapeutic targeting in pediatric low-grade gliomas. Front Oncol 5:54","journal-title":"Front Oncol"},{"key":"394_CR19","doi-asserted-by":"publisher","unstructured":"Porkholm M, Raunio A, Vainionpaa R, Salonen T, Hernesniemi J, Valanne L, Satopaa J, Karppinen A, Oinas M, Tynninen O, Pentikainen V, Kivivuori SM (2018) Molecular alterations in pediatric brainstem gliomas. Pediatr Blood Cancer 65. https:\/\/doi.org\/10.1002\/pbc.26751","DOI":"10.1002\/pbc.26751"},{"issue":"569\u2013583","key":"394_CR20","first-page":"e565","volume":"37","author":"S Ryall","year":"2020","unstructured":"Ryall S, Zapotocky M, Fukuoka K et al (2020) Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas. Cancer Cell 37(569\u2013583):e565","journal-title":"Cancer Cell"},{"key":"394_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11060-007-9507-z","volume":"87","author":"KA Schellinger","year":"2008","unstructured":"Schellinger KA, Propp JM, Villano JL, McCarthy BJ (2008) Descriptive epidemiology of primary spinal cord tumors. J Neurooncol 87:173\u2013179","journal-title":"J Neurooncol"},{"key":"394_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00401-015-1492-2","volume":"131","author":"GM Shankar","year":"2016","unstructured":"Shankar GM, Lelic N, Gill CM, Thorner AR, Van Hummelen P, Wisoff JH, Loeffler JS, Brastianos PK, Shin JH, Borges LF, Butler WE, Zagzag D, Brody RI, Duhaime AC, Taylor MD, Hawkins CE, Louis DN, Cahill DP, Curry WT, Meyerson M (2016) BRAF alteration status and the histone H3F3A gene K27M mutation segregate spinal cord astrocytoma histology. Acta Neuropathol 131:147\u2013150","journal-title":"Acta Neuropathol"},{"key":"394_CR23","doi-asserted-by":"crossref","unstructured":"Takai K, Tanaka S, Sota T, Mukasa A, Komori T, Taniguchi M (2017) Spinal cord astrocytoma with isocitrate dehydrogenase 1 gene mutation. World Neurosurg 108:991 e913\u2013991 e916","DOI":"10.1016\/j.wneu.2017.08.142"},{"key":"394_CR24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/jcp.21978","volume":"222","author":"RG Tatevossian","year":"2010","unstructured":"Tatevossian RG, Lawson AR, Forshew T, Hindley GF, Ellison DW, Sheer D (2010) MAPK pathway activation and the origins of pediatric low-grade astrocytomas. J Cell Physiol 222:509\u2013514","journal-title":"J Cell Physiol"},{"key":"394_CR25","doi-asserted-by":"publisher","first-page":"16244","DOI":"10.1074\/jbc.M501185200","volume":"280","author":"NH Tran","year":"2005","unstructured":"Tran NH, Wu X, Frost JA (2005) B-Raf and Raf-1 are regulated by distinct autoregulatory mechanisms. J Biol Chem 280:16244\u201316253","journal-title":"J Biol Chem"},{"key":"394_CR26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"H Yan","year":"2009","unstructured":"Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765\u2013773","journal-title":"N Engl J Med"},{"key":"394_CR27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00401-018-1874-3","volume":"136","author":"RR Yang","year":"2018","unstructured":"Yang RR, Aibaidula A, Wang WW, Chan AK, Shi ZF, Zhang ZY, Chan DTM, Poon WS, Liu XZ, Li WC, Zhang RQ, Li YX, Chung NY, Chen H, Wu J, Zhou L, Li KK, Ng HK (2018) Pediatric low-grade gliomas can be molecularly stratified for risk. Acta Neuropathol 136:641\u2013655","journal-title":"Acta Neuropathol"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-021-00394-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10014-021-00394-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-021-00394-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T04:54:29Z","timestamp":1697950469000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10014-021-00394-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,28]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["394"],"URL":"https:\/\/doi.org\/10.1007\/s10014-021-00394-2","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"type":"print","value":"1433-7398"},{"type":"electronic","value":"1861-387X"}],"subject":[],"published":{"date-parts":[[2021,2,28]]},"assertion":[{"value":"27 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standard"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}